PT - JOURNAL ARTICLE AU - Özkan, Alican AU - Merry, Gwenn AU - Chou, David B. AU - Posey, Ryan R. AU - Stejskalova, Anna AU - Calderon, Karina AU - Sperry, Megan AU - Horvath, Viktor AU - Ferri, Lorenzo E. AU - Carlotti, Emanuela AU - McDonald, Stuart A. C. AU - Winton, Douglas J. AU - Riccardi, Rocco AU - Bordeianou, Lilianna AU - Hall, Sean AU - Goyal, Girija AU - Ingber, Donald E. TI - Inflammatory Bowel Disease Drivers Revealed in Human Organ Chips AID - 10.1101/2024.12.05.24318563 DP - 2024 Jan 01 TA - medRxiv PG - 2024.12.05.24318563 4099 - http://medrxiv.org/content/early/2024/12/08/2024.12.05.24318563.short 4100 - http://medrxiv.org/content/early/2024/12/08/2024.12.05.24318563.full AB - Inflammatory bowel disease (IBD) patients exhibit compromised intestinal barrier function and decreased mucus accumulation, as well as increased inflammation, fibrosis, and cancer risk, with symptoms often being exacerbated in women during pregnancy. Here, we show that these IBD hallmarks can be replicated using human Organ Chips lined by IBD patient-derived colon epithelial cells interfaced with matched fibroblasts cultured under flow. Use of heterotypic tissue recombinants revealed that IBD fibroblasts are the primary drivers of multiple IBD symptoms. Inflammation and fibrosis are accentuated by peristalsis-like motions in IBD Chips and when exposed to pregnancy-associated hormones in female IBD Chips. Carcinogen exposure also increases inflammation, gene mutations, and chromosome duplication in IBD Chips, but not in Healthy Chips. These data enabled by human Organ Chip technology suggest that the intestinal stroma and peristalsis-associated mechanical deformations play a key role in driving inflammation and disease progression in male and female IBD patients.Competing Interest StatementD.E.I. holds equity in Emulate, chairs its scientific advisory board and is a member of its board of directors. The other authors declare no competing interests.Funding StatementThis work was funded in part by Cancer Research UK (C19767/A27145 to DEI) and by the Wyss Institute for Biologically Inspired Engineering at Harvard University as well as by an NIH training grants (5T32DK007199-44 and 5T32EB016652-10 to AO). We thank Harvard Digestive Diseases Center Organoid Core for providing L-WRN conditioned media.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All methods were performed in accordance with the Institutional Review Board of Massachusetts General Hospital approval (protocol number IRB-2015P001859) and McGill University Health Centre (protocol number REB-2007-856).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData that support the findings of this study are available within the paper and its Supplementary Information files. The RNA sequencing data have been deposited in the Gene Expression Omnibus (GEO) with the accession code GSE277964. Any other material including the R code used for data analysis is available upon reasonable request.